BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38433686)

  • 21. Recombinant allergen profiles and health-related quality of life in seasonal allergic rhinitis.
    Canis M; Gröger M; Becker S; Klemens C; Kramer MF
    Allergy Asthma Proc; 2010; 31(3):219-26. PubMed ID: 20615322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics of allergen component in dust mite-induced allergic rhinitis patients].
    Chen H; Ji P; Yang L; Huang N; Jiang Q; Yang Y; Zhu R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Jun; 37(6):442-447. PubMed ID: 37253517
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessing IgE sensitization profiles to birch and timothy grass pollen allergens in birch pollen allergic blood donors using an oligoplex specific IgE assay.
    Mahmood F; Nissen-Meyer LSH; Hetland G; Nentwich I
    Scand J Clin Lab Invest; 2023 Nov; 83(7):444-447. PubMed ID: 37737679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M; Marth K; Valenta R
    Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral Allergy Syndrome Following Soy Milk Ingestion in Patients with Birch Pollen Allergy].
    Yamamoto T; Asakura K; Shirasaki H; Himi T
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Sep; 118(9):1124-32. PubMed ID: 26615663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments.
    Campana R; Moritz K; Marth K; Neubauer A; Huber H; Henning R; Blatt K; Hoermann G; Brodie TM; Kaider A; Valent P; Sallusto F; Wöhrl S; Valenta R
    J Allergy Clin Immunol; 2016 Feb; 137(2):601-609.e8. PubMed ID: 26518092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens.
    Mittag D; Vieths S; Vogel L; Becker WM; Rihs HP; Helbling A; Wüthrich B; Ballmer-Weber BK
    J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of perennial dust mites allergy on symptom severity of autumn allergic rhinitis in adults.
    Xu Q; Zhang Y; Zhang L
    Allergy Asthma Proc; 2020 Sep; 41(5):363-371. PubMed ID: 32867891
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy.
    Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ
    Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Birch allergy and oral allergy syndrome: The practical relevance of serum immunoglobulin E to Bet v 1.
    Ciprandi G; Comite P; Ferrero F; Bignardi D; Minale P; Voltolini S; Troise C; Mussap M
    Allergy Asthma Proc; 2016; 37(1):43-9. PubMed ID: 26831846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Birch pollen allergy].
    Lavaud F; Fore M; Fontaine JF; Pérotin JM; de Blay F
    Rev Mal Respir; 2014 Feb; 31(2):150-61. PubMed ID: 24602682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
    Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
    PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
    van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
    J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
    Akinfenwa O; Huang HJ; Linhart B; Focke-Tejkl M; Vrtala S; Poroshina A; Nikonova A; Khaitov M; Campion NJ; Eckl-Dorna J; Niederberger-Leppin V; Kratzer B; Tauber PA; Pickl WF; Kundi M; Campana R; Valenta R
    Front Immunol; 2021; 12():744544. PubMed ID: 34795666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical benefit of component-resolved diagnosis in Japanese birch-allergic patients with a convincing history of apple or peach allergy.
    Shirasaki H; Yamamoto T; Abe S; Kanaizumi E; Kikuchi M; Himi T
    Auris Nasus Larynx; 2017 Aug; 44(4):442-446. PubMed ID: 27816237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum immunoglobulin E reactivity to cross-reacting panallergen components in north-eastern Poland patients pollen sensitized.
    Kowal K; Pampuch A; Sacharzewska E; Swiebocka E; Siergiejko Z; Siergiejko G; Chruszcz M; DuBuske L
    Allergy Asthma Proc; 2020 May; 41(3):183-191. PubMed ID: 32375962
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
    Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
    J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.